Feline Triple Vaccine Description
This inactivated combination vaccine is formulated to protect cats against three major infectious diseases: feline herpesvirus type 1 (FHV-1), feline calicivirus (FCV), and feline parvovirus (FPV).
Feline upper respiratory infections caused by FHV-1 and FCV are highly contagious and commonly seen in shelters, catteries, and multi-cat environments, leading to significant morbidity. Meanwhile, feline panleukopenia is a highly fatal disease, especially in kittens, characterized by severe leukopenia and gastrointestinal damage.
This vaccine contains well-selected strains (WX, SH14, and 0918) with high antigen content, ensuring strong immunogenicity while maintaining excellent safety due to its inactivated formulation.
Following the complete primary vaccination course, protective immunity develops within 10 days after the second dose, providing 12 months of effective protection. It is ideal for routine immunization programs in veterinary clinics, pet hospitals, and large-scale breeding operations.
免疫プログラム
- Primary Vaccination (Kittens ≥ 8 weeks old):
- First dose: 1.0 mL
- Second dose: 1.0 mL after 21–28 days
- 追加免疫接種:
- Annual revaccination (1.0 mL)
用法・用量
- 接種経路：皮下注射
- Dosage: 1.0 mL per cat
抗原組成
Each 1.0 mL dose contains:
- Feline herpesvirus type 1 (FHV-1, strain WX): ≥ 10⁷.⁰ TCID50 (before inactivation)
- Feline calicivirus (FCV, strain SH14): ≥ 10⁸.⁰ TCID50
- Feline parvovirus (FPV, strain 0918): ≥ 10⁴.⁰ TCID50
Safety Profile
- 一般的に、 目立った副反応は認められません 認められていません
- Rare allergic reactions may occur due to individual sensitivity
- In case of hypersensitivity:
- Immediate administration of epinephrine is recommended
- Supportive therapy as needed
包装および仕様
- 仕様：1 mL/バイアル
- 包装: 25 vials/box
保存方法と有効期間
- 保存：2～8°C、遮光
- 凍結しないでください
- 有効期間：24か月
注意点
- 以下にのみ使用 healthy cats ≥ 8 weeks old
- 使用前にワクチンを室温に戻し、よく振ってください
- 開封後は直ちに使用してください
- 無菌的な注射手順を維持すること
- Dispose of used materials safely
